Surface epithelialization of the type i Boston keratoprosthesis front plate: Immunohistochemical and high-definition optical coherence tomography characterization

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 8, 2012, Pages 1195-1199

  Kiang, Lee ^a,b   Rosenblatt, Mark I ^a,b   Sartaj, Rachel ^b   Fernandez, Ana G Alzaga ^a   Kiss, Szilard ^a   Radcliffe, Nathan M ^a   D'Amico, Donald J ^a   Sippel, Kimberly C ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bio integration; Corneal epithelium; Keratoprosthesis

Indexed keywords

ANTIGLAUCOMA AGENT; CORTICOSTEROID; CYTOKERATIN 3; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

AGED; ARTICLE; CASE REPORT; CLOSED ANGLE GLAUCOMA; CONGENITAL GLAUCOMA; CORNEA EPITHELIUM; CORNEA THICKNESS; CORNEA TRANSPLANTATION; FEMALE; HIGH DEFINITION OPTICAL COHERENCE TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KERATOPATHY; KERATOPROSTHESIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SLIT LAMP; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ARTIFICIAL ORGANS; CORNEA; EPITHELIUM, CORNEAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KERATIN-3; MALE; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84865809608     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-1960-5     Document Type: Article

References (22)

1. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH (2001) Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 119:484-489
2. Fintelmann RE, Maguire JI, Ho AC, Chew HF, Ayres BD (2009) Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea 28:877-878
3. Yaghouti F, Nouri M, Abad JC, Power WJ, Doane MG, Dohlman CH (2001) Keratoprosthesis: preoperative prognostic categories. Cornea 20:19-23
4. Utine CA, Tzu JH, Akpek EK (2011) Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt. Ocul Immunol Inflamm 19:413-418
5. Colby KA, Koo EB (2011) Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol 22:267-273
6. Aldave AJ, Kamal KM, Vo RC, Yu F (2009) The Boston type I Keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 116:640-651
7. Basu S, Taneja M, Sangwan VS (2011) Boston type I keratoprosthesis for severe blinding vernal keratoconjunctivitis and Mooren's ulcer. Int Ophthalmol 31:219-222
8. Robert MC, Harissi-Dagher M (2011) Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol 46:164-168
9. Dunlap K, Chak G, Aquavella JV, Myrowitz E, Utine CA, Akpek E (2010) Short-term visual outcomes of Boston type 1 Keratoprosthesis implantation. Ophthalmology 117:687-692
10. Traish AS, Chodosh J (2010) Expanding application of the Boston type I Keratoprosthesis due to advances in design and improved Post-operative therapeutic strategies. Semin Ophthalmol 25:239-243
11. Bradley J, Hernandez E, Schwab I, Mannis M (2009) Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 28:321-327
12. Chew H, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, Jin YP, Cohen EJ (2009) Boston keratoprosthesis outcomes and complications. Cornea 28:989-996
13. Zerbe BL, Belin MW, Ciolino JB (2006) Results from the multicenter Boston type 1 Keratoprosthesis study. Ophthalmology 113:1779-1784
14. Klufas MA, Colby KA (2010) The Boston keratoprosthesis. Int Ophthalmol Clin 50:161-175
15. Khalifa YM, Davis D, Mamalis N, Moshirfar M (2010) Epithelial growth over the optic surface of the type I Boston keratoprosthesis: histopathology and implications for biointegration. Clin Ophthalmol 4:1069-1071
16. Nishida K, Adachi W, Shimizu-Matsumoto A, Kinoshita S, Mizuno K, Matsubara K, Okubo K (1996) A gene expression profile of human corneal epithelium and the isolation of human keratin 12 cDNA. Invest Ophthalmol Vis Sci 37:1800-1809
17. Proulx S, JdA U, Carrier P, Deschambeault A, Audet C, Giasson CJ, Guerin SL, Auger FA, Germain L (2010) Reconstruction of a human cornea by the self-assembly approach of tissue engineering using the three native cell types. Mol Vis 16:2192-2201
18. Ciolino JB, Dohlman CH (2009) Biologic keratoprosthesis materials. Int Ophthalmol Clin 49:1-9
19. Khan B, Harissi-Dagher M, Khan D, Dohlman C (2007) Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 47:61-71
20. Durand M, Dohlman CH (2009) Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 28:896-901
21. Garcia JJ, Ritterband D, Buxton D, De la Cruz J (2010) Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography. Cornea 9:1031-1035
22. Karkhaneh A, Mirzadeh H,GhaffariyehA, Ebrahimi A,Honarpisheh N, Hosseinzadeh M, Heidari MH (2010) Novel materials to enhance corneal epithelial cellmigration on keratoprosthesis. Br J Ophthalmol 95:405-409